Good morning :)
Place Order
Add to Watchlist

Shukra Pharmaceuticals Ltd

SHUKRAPHAR

Shukra Pharmaceuticals Ltd

SHUKRAPHAR
Health CarePharmaceuticals
SmallcapWith a market cap of ₹1,097 cr, stock is ranked 1,304
High RiskStock is 3.80x as volatile as Nifty
245.701.99% (-5.00)
245.701.99% (-5.00)

Price Chart

High
—
Low
—
Returns
—
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Health CarePharmaceuticals
SmallcapWith a market cap of ₹1,097 cr, stock is ranked 1,304
High RiskStock is 3.80x as volatile as Nifty
Scorecard

Performance

High

The creamy layer - amongst the top performing stocks

Valuation

High

Seems to be overvalued vs the market average

Growth

High

Strong financials and growth story over the years

Profitability

High

Showing good signs of profitability & efficiency

Entry point

Avg

The stock is not in the overbought zone

Red flags

Low

No red flag found

How to use scorecard? Learn more

Health CarePharmaceuticals
SmallcapWith a market cap of ₹1,097 cr, stock is ranked 1,304
High RiskStock is 3.80x as volatile as Nifty

Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
134.6919.050.10%
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
47.316.040.55%

Forecast & Ratings

Detailed Forecast 
—
Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Shukra Pharmaceuticals is engaged in the business of manufacturing and trading of pharmaceuticals Products.

Peers

Compare with peers 
Sun Pharmaceutical Industries Ltd
SUNPHARMA
PE Ratio
42.70
1Y Return
8.47%
Buy Reco %
88.24
Cipla Ltd
CIPLA
PE Ratio
29.25
1Y Return
0.28%
Buy Reco %
72.73
Torrent Pharmaceuticals Ltd
TORNTPHARM
PE Ratio
62.65
1Y Return
19.33%
Buy Reco %
68.00
Dr Reddy's Laboratories Ltd
DRREDDY
PE Ratio
17.19
1Y Return
9.27%
Buy Reco %
45.16
Lupin Ltd
LUPIN
PE Ratio
47.50
1Y Return
23.38%
Buy Reco %
63.64
Compare with Peers

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

Forecasts

Price

Revenue

Earnings

Price Forecast

Hmm, looks like data is unavailable here. Please come back after some time

Revenue Forecast

Hmm, looks like data is unavailable here. Please come back after some time

Earnings Per Share Forecast

Hmm, looks like data is unavailable here. Please come back after some time

Income

Balance Sheet

Cash Flow

Income Statement

Industry refers to the sub-sector this company belongs to.

Higher than Industry Revenue Growth

A higher-than-industry revenue growth represents increased potential for the company to increase their market share

Over the last 5 years, revenue has grown at a yearly rate of 68.49%, vs industry avg of 9.04%

Increasing Market Share

Market share is the percentage of an industry's total sales going to a particular company. It gives a general idea of the size of a company v/s its competitors

Over the last 5 years, market share increased from 0% to 0.02%

Higher than Industry Net Income

Net income is equal to net earnings (profit) less expenses. This number is an important measure of how profitable the company is

Over the last 5 years, net income has grown at a yearly rate of 109.47%, vs industry avg of 15.28%

Loading...

Financial YearFY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024TTM
Total Revenue5.015.215.485.7011.9511.5620.5760.0377.3934.32
Raw Materialssubtract1.640.950.891.163.332.9611.0845.6543.7820.36
Power & Fuel Costsubtract0.260.260.290.341.641.780.000.000.00
Employee Costsubtract1.131.051.231.914.343.754.574.415.02
Selling & Administrative Expensessubtract0.440.921.200.711.211.362.443.385.15
Operating & Other expensessubtract0.750.490.15-0.11-0.210.10-0.490.031.21
Depreciation/Amortizationsubtract0.450.470.740.961.481.471.661.842.052.59
Interest & Other Itemssubtract0.000.010.040.000.000.030.290.280.290.39
Taxes & Other Itemssubtract0.230.550.420.270.14-0.090.270.041.342.83
EPS0.040.170.170.150.010.070.252.427.401.86
DPS0.000.030.030.030.000.000.030.130.251.00
Payout ratio0.000.150.150.170.000.000.100.050.030.54
See Costs

EPS and DPS in ₹. Other numbers except Payout Ratio in ₹ cr

Company Updates

Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange
FY 2015

Annual report

PDF
FY 2016

Annual report

PDF
FY 2017

Annual report

PDF
FY 2018

Annual report

PDF
FY 2019

Annual report

PDF
FY 2020

Annual report

PDF
FY 2021

Annual report

PDF
FY 2022

Annual report

PDF
FY 2023

Annual report

PDF
FY 2024

Annual report

PDF
 

Peers & Comparison

Comparing 3 stocks from 
Health CarePharmaceuticals

Valuation

Technical

Forecast

ScreenerCompare valuation on Screener

Loading...

StockPE RatioPE RatioPB RatioPB RatioDiv. YieldDividend Yield
Shukra Pharmaceuticals Ltd59.1819.050.10%
Sun Pharmaceutical Industries Ltd42.706.090.79%
Cipla Ltd29.254.500.87%
Torrent Pharmaceuticals Ltd62.6515.140.91%

Price Comparison

Compare SHUKRAPHAR with any stock or ETF
Compare SHUKRAPHAR with any stock or ETF
SHUKRAPHAR
Loading...

Shareholdings

Promoter Holdings Trend

Total Promoter Holding

Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding

Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Institutional Holdings Trend

Total Retail Holding

Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.

In last 3 months, retail holding in the company has almost stayed constant

Foreign Institutional Holding

Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock

In last 3 months, foreign institutional holding of the company has almost stayed constant

Tickertape Separator

Shareholding Pattern

Retail and OthersForeign InstitutionsOther Domestic InstitutionsMutual FundsTotal Promoter Holding50.96%0.00%0.11%0.00%48.93%

Mar 2024

Jun 2024

Sep 2024

Dec 2024

Shareholding History

SepDec '23MarJunSepDec '240.00%0.00%0.00%0.00%0.00%0.00%

Insider Trades & Bulk Deals

Hmm, looks like there hasn't been any net deal activity in the last 6 months

smallcases

Looks like this stock is not in any smallcase yet.

Events

Dividend Trend

No dividend trend available

Dividends

Corp. Actions

Announcements

Legal Orders

Upcoming Dividends

No upcoming dividends are available

Past Dividends

Cash Dividend

Ex DateEx DateSep 23, 2024

Final
Final | Div/Share: ₹1.00

Dividend/Share

₹1.00

Ex DateEx Date

Sep 23, 2024

Cash Dividend

Ex DateEx DateSep 15, 2023

Final
Final | Div/Share: ₹0.50

Dividend/Share

₹0.50

Ex DateEx Date

Sep 15, 2023

Cash Dividend

Ex DateEx DateSep 22, 2022

Final
Final | Div/Share: ₹0.50

Dividend/Share

₹0.50

Ex DateEx Date

Sep 22, 2022

Cash Dividend

Ex DateEx DateSep 19, 2019

Final
Final | Div/Share: ₹0.50

Dividend/Share

₹0.50

Ex DateEx Date

Sep 19, 2019

Cash Dividend

Ex DateEx DateAug 31, 2018

Final
Final | Div/Share: ₹0.50

Dividend/Share

₹0.50

Ex DateEx Date

Aug 31, 2018

News & Opinions
Corporate
Shukra Pharmaceuticals fixes record date for Stock Split

Shukra Pharmaceuticals has fixed 21 March 2025 as the record date to ascertain the eligibility of Shareholders for the purpose of sub-division / split of the Equity Shares of the comp-any such that every 1(one) Equity Share having nominal/face value of Rs. 10/- [Rupees Ten 0niyJ each be sub-divided into 10 [Ten) Equity shares having nominal/face value of Rs. 1/- (Rupees one 0nly) each.Powered by Capital Market - Live

1 week agoCapital Market - Live
Earnings
Shukra Pharmaceuticals standalone net profit declines 66.45% in the December 2024 quarter

Net profit of Shukra Pharmaceuticals declined 66.45% to Rs 3.16 crore in the quarter ended December 2024 as against Rs 9.42 crore during the previous quarter ended December 2023. Sales declined 43.99% to Rs 10.58 crore in the quarter ended December 2024 as against Rs 18.89 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales10.5818.89 -44 OPM %37.1550.50 - PBDT4.7910.03 -52 PBT4.099.52 -57 NP3.169.42 -66 Powered by Capital Market - Live

1 month agoCapital Market - Live
Corporate
Shukra Pharmaceuticals to convene board meeting

Shukra Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 14 February 2025.Powered by Capital Market - Live

1 month agoCapital Market - Live
Corporate
Shukra Pharmaceuticals to consider Stock Split

Shukra Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 29 January 2025.Powered by Capital Market - Live

1 month agoCapital Market - Live
Corporate
Shukra Pharmaceuticals to hold board meeting

Shukra Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 9 January 2025.Powered by Capital Market - Live

2 months agoCapital Market - Live
Earnings
Shukra Pharmaceuticals standalone net profit declines 88.54% in the September 2024 quarter

Net profit of Shukra Pharmaceuticals declined 88.54% to Rs 0.54 crore in the quarter ended September 2024 as against Rs 4.71 crore during the previous quarter ended September 2023. Sales declined 77.44% to Rs 5.56 crore in the quarter ended September 2024 as against Rs 24.64 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales5.5624.64 -77 OPM %12.0520.62 - PBDT1.585.26 -70 PBT0.884.70 -81 NP0.544.71 -89 Powered by Capital Market - Live

4 months agoCapital Market - Live
Corporate
Shukra Pharmaceuticals to discuss results

Shukra Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 14 November 2024Powered by Capital Market - Live

4 months agoCapital Market - Live
Corporate
Shukra Pharmaceuticals schedules board meeting

Shukra Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 28 September 2024.Powered by Capital Market - Live

5 months agoCapital Market - Live
Corporate
Shukra Pharmaceuticals to hold AGM

Shukra Pharmaceuticals announced that the 31th Annual General Meeting (AGM) of the company will be held on 30 September 2024.Powered by Capital Market - Live

6 months agoCapital Market - Live
Earnings
Shukra Pharmaceuticals standalone net profit rises 16.67% in the June 2024 quarter

Net profit of Shukra Pharmaceuticals rose 16.67% to Rs 0.49 crore in the quarter ended June 2024 as against Rs 0.42 crore during the previous quarter ended June 2023. Sales declined 84.23% to Rs 3.18 crore in the quarter ended June 2024 as against Rs 20.16 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales3.1820.16 -84 OPM %25.791.69 - PBDT1.480.89 66 PBT0.810.43 88 NP0.490.42 17 Powered by Capital Market - Live

7 months agoCapital Market - Live

Frequently asked questions

  1. What is the share price of Shukra Pharmaceuticals Ltd (SHUKRAPHAR) today?

    The share price of SHUKRAPHAR as on 18th March 2025 is ₹245.70. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.

  2. What is the return on Shukra Pharmaceuticals Ltd (SHUKRAPHAR) share?

    The past returns of Shukra Pharmaceuticals Ltd (SHUKRAPHAR) share are
    • Past 1 week: 6.09%
    • Past 1 month: 21.35%
    • Past 3 months: 185.08%
    • Past 6 months: 293.81%
    • Past 1 year: 251.32%
    • Past 3 years: 7923.23%
    • Past 5 years: 10194.76%

  3. What are the peers or stocks similar to Shukra Pharmaceuticals Ltd (SHUKRAPHAR)?

    The peers or stocks similar to Shukra Pharmaceuticals Ltd (SHUKRAPHAR) include:

  4. What is the dividend yield % of Shukra Pharmaceuticals Ltd (SHUKRAPHAR) share?

    The current dividend yield of Shukra Pharmaceuticals Ltd (SHUKRAPHAR) is 0.10.

  5. What is the market cap of Shukra Pharmaceuticals Ltd (SHUKRAPHAR) share?

    Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Shukra Pharmaceuticals Ltd (SHUKRAPHAR) is ₹1097.76 Cr as of 18th March 2025.

  6. What is the 52 week high and low of Shukra Pharmaceuticals Ltd (SHUKRAPHAR) share?

    The 52-week high of Shukra Pharmaceuticals Ltd (SHUKRAPHAR) is ₹271.50 and the 52-week low is ₹57.52.

  7. What is the PE and PB ratio of Shukra Pharmaceuticals Ltd (SHUKRAPHAR) stock?

    The P/E (price-to-earnings) ratio of Shukra Pharmaceuticals Ltd (SHUKRAPHAR) is 59.18. The P/B (price-to-book) ratio is 19.05.

  8. Which sector does Shukra Pharmaceuticals Ltd (SHUKRAPHAR) belong to?

    Shukra Pharmaceuticals Ltd (SHUKRAPHAR) belongs to the Health Care sector & Pharmaceuticals sub-sector.

  9. How to buy Shukra Pharmaceuticals Ltd (SHUKRAPHAR) shares?

    You can directly buy Shukra Pharmaceuticals Ltd (SHUKRAPHAR) shares on Tickertape. Simply sign up, connect your demat account and place your order.